Sara F Milrad1, Daniel L Hall2, Devika R Jutagir1, Emily G Lattie3, Sara J Czaja4, Dolores M Perdomo4, Mary Ann Fletcher5, Nancy Klimas5, Michael H Antoni6. 1. Department of Psychology, University of Miami, United States. 2. Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, United States; Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Harvard Medical School, United States. 3. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, United States. 4. Department of Psychiatry and Behavioral Sciences, University of Miami, United States. 5. Institute for Neuro Immune Medicine, Nova Southeastern University, United States. 6. Department of Psychology, University of Miami, United States. Electronic address: mantoni@miami.edu.
Abstract
INTRODUCTION: Chronic Fatigue Syndrome (CFS) is a poorly understood illness that is characterized by diverse somatic symptoms, hypothalamic pituitary adrenal (HPA) axis dysfunction and heightened inflammatory indicators. These symptoms are often exacerbated and accompanied by psychological distress states and depression. Since depression is known to be associated with HPA axis dysfunction and greater inflammation, a psychoneuroendocrinological (PNE) model of inflammation was examined in persons diagnosed with CFS in order to uncover underlying biopsychosocial mechanisms in this poorly understood chronic illness. METHODS: Baseline data were drawn from two randomized controlled trials testing the efficacy of different forms of psychosocial intervention, and included psychological questionnaires, di-urnal salivary cortisol, and blood samples. Data were analyzed with structural equation modeling (SEM). RESULTS: The sample (N=265) was mostly middle-aged (Mage=49.36±10.9, range=20-73years), Caucasian (67.7%), female (81.7%), highly educated (85.5% completed some college, college, or graduate program), and depressed (CES-D M=23.87±12.02, range 2-57). The SEM supporting a psychoneuroendocrinological model of immune dysregulation in CFS fit the data χ2 (12)=17.725, p=0.1243, RMSEA=0.043, CFI=0.935, SRMR=0.036. Depression was directly related to evening salivary cortisol and inflammation, such that higher evening cortisol predicted greater depressive symptoms (β=0.215, p<0.01) and higher pro-inflammatory cytokines (interleukin-2 [IL-2], IL-6, and tumor necrosis factor-alpha [TNF-α] levels (β=0.185, p<0.05), when controlling for covariates. DISCUSSION: Results highlight the role of depression, cortisol and inflammation in possible biological mechanisms involved in the pathophysiology of CFS. Time-lagged, longitudinal analyses are needed to fully explore these relationships.
INTRODUCTION:Chronic Fatigue Syndrome (CFS) is a poorly understood illness that is characterized by diverse somatic symptoms, hypothalamic pituitary adrenal (HPA) axis dysfunction and heightened inflammatory indicators. These symptoms are often exacerbated and accompanied by psychological distress states and depression. Since depression is known to be associated with HPA axis dysfunction and greater inflammation, a psychoneuroendocrinological (PNE) model of inflammation was examined in persons diagnosed with CFS in order to uncover underlying biopsychosocial mechanisms in this poorly understood chronic illness. METHODS: Baseline data were drawn from two randomized controlled trials testing the efficacy of different forms of psychosocial intervention, and included psychological questionnaires, di-urnal salivary cortisol, and blood samples. Data were analyzed with structural equation modeling (SEM). RESULTS: The sample (N=265) was mostly middle-aged (Mage=49.36±10.9, range=20-73years), Caucasian (67.7%), female (81.7%), highly educated (85.5% completed some college, college, or graduate program), and depressed (CES-D M=23.87±12.02, range 2-57). The SEM supporting a psychoneuroendocrinological model of immune dysregulation in CFS fit the data χ2 (12)=17.725, p=0.1243, RMSEA=0.043, CFI=0.935, SRMR=0.036. Depression was directly related to evening salivary cortisol and inflammation, such that higher evening cortisol predicted greater depressive symptoms (β=0.215, p<0.01) and higher pro-inflammatory cytokines (interleukin-2 [IL-2], IL-6, and tumor necrosis factor-alpha [TNF-α] levels (β=0.185, p<0.05), when controlling for covariates. DISCUSSION: Results highlight the role of depression, cortisol and inflammation in possible biological mechanisms involved in the pathophysiology of CFS. Time-lagged, longitudinal analyses are needed to fully explore these relationships.
Authors: Daniel L Hall; Emily G Lattie; Michael H Antoni; Mary Ann Fletcher; Sara Czaja; Dolores Perdomo; Nancy G Klimas Journal: Psychoneuroendocrinology Date: 2014-07-06 Impact factor: 4.905
Authors: Dianne Lorton; Cheri L Lubahn; Chris Estus; Brooke A Millar; Jeffery L Carter; Carlo A Wood; Denise L Bellinger Journal: Neuroimmunomodulation Date: 2007-08-06 Impact factor: 2.492
Authors: Elise Vangeel; Filip Van Den Eede; Titia Hompes; Benedetta Izzi; Jurgen Del Favero; Greta Moorkens; Diether Lambrechts; Kathleen Freson; Stephan Claes Journal: Psychosom Med Date: 2015-10 Impact factor: 4.312
Authors: Ana Belén Fernández-Serrano; Francisco José Moya-Faz; Cesar Augusto Giner Alegría; Juan Carlos Fernández Rodríguez Journal: Brain Behav Date: 2022-05-19 Impact factor: 3.405
Authors: David Villarreal-Zegarra; Rubí Paredes-Angeles; Nikol Mayo-Puchoc; Ana L Vilela-Estada; Anthony Copez-Lonzoy; Jeff Huarcaya-Victoria Journal: BMC Psychiatry Date: 2022-10-10 Impact factor: 4.144